Prakash Satwani
NewYork–Presbyterian Hospital(US)Columbia University Irving Medical Center(US)New York Hospital Queens(US)Clinical Research Consortium(US)Columbia University(US)
Publications by Year
Research Areas
Hematopoietic Stem Cell Transplantation, Acute Lymphoblastic Leukemia research, Immune Cell Function and Interaction, Childhood Cancer Survivors' Quality of Life, CAR-T cell therapy research
Most-Cited Works
- → Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research(2014)433 cited
- → A Phase 3, Single-Arm, Prospective Study of Remestemcel-L, Ex Vivo Culture-Expanded Adult Human Mesenchymal Stromal Cells for the Treatment of Pediatric Patients Who Failed to Respond to Steroid Treatment for Acute Graft-versus-Host Disease(2020)180 cited
- → Allogeneic hematopoietic cell transplantation for XIAP deficiency: an international survey reveals poor outcomes(2012)142 cited
- → Characterization of COVID‐19 disease in pediatric oncology patients: The New York‐New Jersey regional experience(2020)117 cited
- → Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy(2021)105 cited
- → Reduced toxicity, myeloablative conditioning with BU, fludarabine, alemtuzumab and SCT from sibling donors in children with sickle cell disease